<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01954758</url>
  </required_header>
  <id_info>
    <org_study_id>1304-C-107-CS</org_study_id>
    <nct_id>NCT01954758</nct_id>
  </id_info>
  <brief_title>The ERA Test as a Diagnostic Guide for Personalized Embryo Transfer</brief_title>
  <official_title>Clinical Study, International, Multicentre, Prospective, Randomised, Interventional and Controlled, Comparing Fresh Embryo Transfer (ET) Versus Elective Delayed Embryo Transfer (DET) and Personalised Embryo Transfer (pET) Guided by the ERA (Endometrial Receptivity Array) Test as a Diagnostic Tool in Patients Treated by IVF/ICSI (in Vitro Fertilisation; Intra-cytoplasmic Sperm Injection)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Igenomix</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Igenomix</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project seeks to demonstrate the clinical value of the personalised diagnosis of the
      endometrial factor in infertility.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This project seeks to investigate differences in implantation (IR), pregnancy (PR), ongoing
      pregnancy (OP) rates and delivery among women undergoing transfer at the blastocyst stage in
      their first IVF/ICSI cycle comparing the normal practice of same-cycle embryo transfer in a
      fresh cycle (ET) versus deferred embryo transfer (DET) versus personalized embryo transfer
      (pET) after endometrial receptivity analysis (ERA).

      A total of 546 infertile women under 38 years old undergoing her first IVF/ICSI cycle with
      elective blastocyst transfer are randomized in this prospective, multicenter, open label and
      controlled trial. Patients are allocated through computer-generated randomization into one of
      the three groups: Fresh embryo transfer (ET), Deferred embryo transfer (DET) or personalized
      embryo transfer (pET) after identification of the personalized window of implantation using
      the ERA test.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Live birth rate</measure>
    <time_frame>40 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Implantation rate</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pregnancy rate</measure>
    <time_frame>20 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biochemical pregnancies</measure>
    <time_frame>20 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ectopic pregnancies</measure>
    <time_frame>20 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical miscarriages</measure>
    <time_frame>20 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ongoing pregnacy rate</measure>
    <time_frame>40 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Obstetric pathologies</measure>
    <time_frame>40 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late gestational miscarriages</measure>
    <time_frame>40 weeks</time_frame>
    <description>Miscarriages after the second and third trimester</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">546</enrollment>
  <condition>Endometrial Receptivity</condition>
  <arm_group>
    <arm_group_label>Arm C-R: pET (ERA)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will undergo a cycle of endometrial preparation following hormone replacement therapy (HRT) and will undergo an endometrial biopsy in this substituted cycle after five days (around 120 hours) of progesterone administration. The ERA test will analyze the endometrial receptivity to determine the most suitable time (the most receptive stage) for the embryo transfer. In a different cycle, patients will undergo a cycle of controlled ovarian stimulation (COS) to obtain oocytes which will be fertilized by IVF/ICSI and vitrified. In a subsequent cycle, if a receptive profile was previously demonstrated by the ERA test, a personalized embryo transfer (pET) will be performed following the same conditions in which the ERA test was obtained using 1 or 2 viable blastocysts previously obtained (day 5 or 6 stage).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm CNR: pET (ERA+ERA)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will undergo a cycle of endometrial preparation following hormone replacement therapy (HRT) and will undergo an endometrial biopsy in this substituted cycle after five days (around 120 hours) of progesterone administration.The ERA test will analyze the endometrial receptivity to determine the most suitable time (the most receptive stage) for the embryo transfer. If the window of implantation (WOI) is displaced (profile non receptive), a new biopsy will be taken on a different day based on the result of the first ERA test to identify the personalized WOI. In a different cycle, patients will undergo a cycle of controlled ovarian stimulation (COS) to obtain oocytes which will be fertilized by IVF/ICSI and vitrified.In a subsequent cycle, a personalized embryo transfer (pET) will take place according to the second ERA test result. A pET using 1 or 2 viable blastocysts previously obtained (day 5 or 6 stage) will be performed following the same conditions as in the second ERA test.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm A: Fresh embryo transfer (ET)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will undergo a controlled ovarian stimulation cycle (COS) to obtain oocytes which will be fertilized by IVF/ICSI. In the same cycle, a fresh embryo transfer will be performed using 1 or 2 viable blastocysts previously obtained (day 5 or 6 stage).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm B: Deferred embryo transfer (DET)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will undergo a cycle of controlled ovarian stimulation (COS) to obtain oocytes which will be fertilized by IVF/ICSI. In a subsequent cycle, following hormone replacement therapy (HRT), an elective deferred embryo transfer (DET) will be performed using 1 or 2 viable blastocysts previously obtained (day 5 or 6 stage).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fresh Embryo Transfer (ET)</intervention_name>
    <arm_group_label>Arm A: Fresh embryo transfer (ET)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Deferred Embryo Transfer (DET)</intervention_name>
    <arm_group_label>Arm B: Deferred embryo transfer (DET)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>personalized Embryo Transfer (pET)</intervention_name>
    <arm_group_label>Arm C-R: pET (ERA)</arm_group_label>
    <arm_group_label>Arm CNR: pET (ERA+ERA)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients indicated to undergo a cycle of IVF/ICSI with their own oocytes.

          2. Age ≤ 37 years

          3. BMI: 18.5 to 30

          4. Normal ovarian reserve (AFC ≥ 8; FSH &lt; 8)

          5. The most appropriate stimulation protocol will be decided by their doctor.

          6. Blastocyst transfer (on day 5 or 6)

          7. Blastocyst vitrification with open protocols (Cryotop, Cryoleaf, or Cryolock) or
             closed protocols (Cryotip or CBSStraw.)

          8. Any pathology affecting the endometrial cavity such as polyps/sub-mucosal myomas,
             intramural myomas &gt; 4 cm, or hydrosalpinx affecting the endometrial cavity must be
             previously operated.

        Exclusion Criteria:

          1. Patients with repeated miscarriages (&gt; 2 previous biochemical pregnancies or &gt; 2
             spontaneous miscarriages)

          2. Patients with a severe male factor (spermatozoa &lt; 2 million/ml)

          3. Patients with implantation failure (&gt;3 failed cycles with good quality embryos)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>37 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlos Simon, MDPhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IVI Valencia / Igenomix</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre of Reproductive Medicine UZ Brussles</name>
      <address>
        <city>Brussels</city>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro de Infertilidade e Medicina Fetal do Norte Fluminence</name>
      <address>
        <city>Campos dos Goytacazes</city>
        <state>Rio De Janeiro</state>
        <zip>28035-210</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro de Reproduçao Humana Nilo Frantz</name>
      <address>
        <city>Porto Alegre</city>
        <state>Rio Grande Del Sur</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Embriofert Clínica Medica Hospitalar Ltda</name>
      <address>
        <city>Sao Paulo</city>
        <zip>01401-002</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Huntington Medicina Reproductiva</name>
      <address>
        <city>Sao Paulo</city>
        <zip>04501-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro de Reprodução Governador Mario Covas</name>
      <address>
        <city>Sao Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sofia Hospital of Reproductive Medicine - SBALAGRM</name>
      <address>
        <city>Sofia</city>
        <zip>1000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oak Clinic Sumiyoshi</name>
      <address>
        <city>Osaka</city>
        <zip>557-0045</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IECH Centro de Fertilidad</name>
      <address>
        <city>Monterrey</city>
        <state>Nuevo Leon</state>
        <zip>64060</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto Vida Matamoros</name>
      <address>
        <city>Matamoros</city>
        <state>Tamaulipas</state>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IVI Panama</name>
      <address>
        <city>Panama</city>
        <zip>0819</zip>
        <country>Panama</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Genesis Ginecological Hospital</name>
      <address>
        <city>Novi Sad</city>
        <zip>210000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>KK Women´s and Children Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>229899</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IVI Bilbao</name>
      <address>
        <city>Leioa</city>
        <state>Bizkaia</state>
        <zip>48940</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IVI Las Palmas</name>
      <address>
        <city>Las Palmas de Gran Canaria</city>
        <state>Las Palmas</state>
        <zip>35010</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IVI Madrid</name>
      <address>
        <city>Aravaca</city>
        <state>Madrid</state>
        <zip>24527</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IVI Vigo</name>
      <address>
        <city>Vigo</city>
        <state>Pontevedra</state>
        <zip>36203</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IVI Alicante</name>
      <address>
        <city>Alicante</city>
        <zip>03015</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IVI Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08017</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ProcreaTec</name>
      <address>
        <city>Madrid</city>
        <zip>28036</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IVI Malaga</name>
      <address>
        <city>Malaga</city>
        <zip>29016</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IVI Murcia</name>
      <address>
        <city>Murcia</city>
        <zip>30007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IVI Sevilla</name>
      <address>
        <city>Sevilla</city>
        <zip>41011</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IVI Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46015</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IVI Zaragoza</name>
      <address>
        <city>Zaragoza</city>
        <zip>50018</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bahceci Health Group</name>
      <address>
        <city>Istanbul</city>
        <zip>34500</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Brazil</country>
    <country>Bulgaria</country>
    <country>Japan</country>
    <country>Mexico</country>
    <country>Panama</country>
    <country>Serbia</country>
    <country>Singapore</country>
    <country>Spain</country>
    <country>Turkey</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 26, 2013</study_first_submitted>
  <study_first_submitted_qc>October 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 7, 2013</study_first_posted>
  <last_update_submitted>November 2, 2017</last_update_submitted>
  <last_update_submitted_qc>November 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto Valenciano de Infertilidad, IVI VALENCIA</investigator_affiliation>
    <investigator_full_name>Carlos Simon</investigator_full_name>
    <investigator_title>Scientific Director IGENOMIX; Gynaecologist IVI Valencia</investigator_title>
  </responsible_party>
  <keyword>Window of implantation</keyword>
  <keyword>Personalized embryo transfer</keyword>
  <keyword>Fresh embryo transfer</keyword>
  <keyword>Delayed embryo transfer</keyword>
  <keyword>Elective deferred embryo transfer</keyword>
  <keyword>Endometrial receptivity array</keyword>
  <keyword>Endometrial receptivity analysis</keyword>
  <keyword>Endometrial receptivity test</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

